Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Cold

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44363   clinical trials with a EudraCT protocol, of which   7387   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    729 result(s) found for: Cold. Displaying page 1 of 37.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2009-016966-97 Sponsor Protocol Number: CAD01 Start Date*: 2010-06-08
    Sponsor Name:Universitätsklinikum Essen
    Full Title: Therapy for Chronic Cold Agglutinin Disease: A Prospective, Non-Randomized, Multi-Center Study Demonstrating the Efficacy of Terminal Complement Inhibition in Patients with Cold Agglutinin Disease ...
    Medical condition: Cold agglutinin disease
    Disease: Version SOC Term Classification Code Term Level
    12.1 10009868 Cold type haemolytic anaemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-006329-42 Sponsor Protocol Number: CAD0111 Start Date*: 2012-10-11
    Sponsor Name:G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO
    Full Title: Short course of Bortezomib in anemic patients with refractory cold agglutinin disease
    Medical condition: Anaemia with refractory cold agglutinin disease
    Disease: Version SOC Term Classification Code Term Level
    14.1 10005329 - Blood and lymphatic system disorders 10009868 Cold type haemolytic anaemia PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-002785-39 Sponsor Protocol Number: BRN-C-2013-04 Start Date*: Information not available in EudraCT
    Sponsor Name:Laboratoires BOIRON
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004862 10009851 Cold LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-004524-11 Sponsor Protocol Number: 2013105 Start Date*: 2013-12-16
    Sponsor Name:Proctor and Gamble Technical Centres Ltd
    Full Title: A 2-arm, randomised, single - (investigator) blind, controlled, parallel design study in common cold sufferers experiencing cough and nasal congestion to assess the effects of Vicks® VapoRub® (VVR)...
    Medical condition: Sleep disruption due to cough and nasal congestion during a cold.
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004862 10000938 Acute nasopharyngitis (common cold) LLT
    14.1 100000004862 10009851 Cold LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-004641-34 Sponsor Protocol Number: RM-0205 Start Date*: 2006-02-07
    Sponsor Name:Matrixx Initiatives Inc
    Full Title: Human Clinical Study: Assessment of Zicam Cold Remedy RapidMelts
    Medical condition: to shorten the duration, reduce the number and decrease the sevity of common cold symptoms in otherwise healthy human adult volunteers
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2005-006133-32 Sponsor Protocol Number: P04685 Start Date*: 2006-09-20
    Sponsor Name:Allergie-Centrum-Charité
    Full Title: An exploratory phase IV, randomised, double-blind, placebo controlled crossover study to assess and compare the effects of 5 mg vs. 20 mg Desloratadine on the development of experimentally induced ...
    Medical condition: Acquired cold urticaria (ACU) is a frequent form of physical urticaria that is characterized by the development of wheal and flare type skin reactions after cold exposure.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10046741 Urticaria cold LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-022441-21 Sponsor Protocol Number: 701004.01.012 Start Date*: 2010-12-13
    Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG
    Full Title: EPs® 7630 film-coated tablets in subjects (≥18 years old) suffering from common cold A prospective, multi-center, single-arm, open-label, phase IV clinical post-marketing safety study
    Medical condition: Common cold
    Disease: Version SOC Term Classification Code Term Level
    14.0 10021881 - Infections and infestations 10010106 Common cold LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2010-022857-41 Sponsor Protocol Number: C6930943 Start Date*: 2010-12-14
    Sponsor Name:GlaxoSmithKline Consumer Healthcare
    Full Title: Effects of a common cold treatment on cognitive function
    Medical condition: Common cold
    Disease: Version SOC Term Classification Code Term Level
    12.1 10000938 Acute nasopharyngitis (common cold) LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-004977-28 Sponsor Protocol Number: 701079.01.013 Start Date*: 2014-02-06
    Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG
    Full Title: Safety and intake effect of EPs®7630 (an extract from the roots of Pelargonium sidoides)
    Medical condition: common cold
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004862 10010106 Common cold LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-005786-35 Sponsor Protocol Number: DC02RUP/IV/02 Start Date*: Information not available in EudraCT
    Sponsor Name:Uriach Pharma
    Full Title: Proof-of-concept, cross over, double blind, placebo-controlled study to assess if Rupatadine 20 mg can improve critical stimulation time thresholds (CSTTs) in patients with acquired cold urticaria
    Medical condition: Acquired Cold Urticaria
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009869 Cold urticaria LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-000860-51 Sponsor Protocol Number: CASK0120 Start Date*: 2020-06-25
    Sponsor Name:Cassella-med GmbH & Co. KG
    Full Title: The effect of early administered cineole on the course of a common cold
    Medical condition: common cold
    Disease: Version SOC Term Classification Code Term Level
    22.1 100000004862 10010106 Common cold LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2011-003746-41 Sponsor Protocol Number: CIGE025EDE14T Start Date*: 2012-01-12
    Sponsor Name:Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin
    Full Title: A two-center, double blind, placebo-controlled study in parallel design to assess the efficacy and safety of 150 and 300 mg omalizumab in subjects with antihistamine-resistant cold contact urticari...
    Medical condition: Cold contact urticaria
    Disease: Version SOC Term Classification Code Term Level
    15.1 10040785 - Skin and subcutaneous tissue disorders 10009869 Cold urticaria PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2021-002039-40 Sponsor Protocol Number: CLNP023L12201 Start Date*: 2021-10-29
    Sponsor Name:Novartis Pharma AG
    Full Title: An open-label, multi-center, phase 2 basket study to assess efficacy, safety and pharmacokinetics of iptacopan (LNP023) in participants with autoimmune benign hematological disorders
    Medical condition: Immune thrombocytopenia (ITP) Cold agglutinin disease (CAD)
    Disease: Version SOC Term Classification Code Term Level
    23.0 10005329 - Blood and lymphatic system disorders 10083842 Immune thrombocytopenia PT
    20.0 10005329 - Blood and lymphatic system disorders 10068863 Cold agglutinin disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) IT (Prematurely Ended) ES (Ongoing)
    Trial results: View results
    EudraCT Number: 2021-002058-96 Sponsor Protocol Number: SAN-0657 Start Date*: 2021-11-16
    Sponsor Name:Lek Pharmaceuticals d.d.
    Full Title: Efficacy and safety of the combination of acetylcysteine, paracetamol and phenylephrine for the treatment of common cold: a prospective, randomized, double-blind, controlled trial
    Medical condition: Common cold and flu-like infections
    Disease: Version SOC Term Classification Code Term Level
    22.1 100000004862 10010106 Common cold LLT
    20.1 100000004862 10000938 Acute nasopharyngitis (common cold) LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Prematurely Ended) PL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-004466-14 Sponsor Protocol Number: RH01361 Start Date*: 2011-10-27
    Sponsor Name:GlaxoSmithKline Consumer Healthcare
    Full Title: Effects of two doses of a common cold treatment on cognitive function
    Medical condition: Common cold
    Disease: Version SOC Term Classification Code Term Level
    14.0 10021881 - Infections and infestations 10000938 Acute nasopharyngitis (common cold) LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2010-021798-34 Sponsor Protocol Number: C7100991 Start Date*: 2010-09-11
    Sponsor Name:GlaxoSmithKline Consumer Healthcare (GSKCH)
    Full Title: To assess the subjective effect of two paracetamol preparations on the feeling of breathing in subjects with the common cold.
    Medical condition: Common cold and flu
    Disease: Version SOC Term Classification Code Term Level
    12.1 10010106 Common cold LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2022-003559-32 Sponsor Protocol Number: CPO19001 Start Date*: 2023-03-16
    Sponsor Name:PharOS Pharmaceutical Oriented Services Single Member Ltd.
    Full Title: A Phase III Prospective, Randomized, Multicenter, Double-Blind, Placebo-controlled clinical study to evaluate the efficacy and safety of fixed dose combination (FDC) product Ibuprofen/Paracetamol/P...
    Medical condition: Temporary relief of cold and flu symptoms, i.e. mild to moderate pain, sore throat, fever and nasal congestion
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004862 10009851 Cold LLT
    21.1 100000004867 10022009 Influenza-like symptoms LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: BG (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005746-22 Sponsor Protocol Number: AECUDATT Start Date*: 2009-05-05
    Sponsor Name:Allergie-Centrum-Charite, Department of Dermatology, Charite - Universitätsmedizin Berlin
    Full Title: Multi-center, double blind, dose escalating study to compare the effects of 5 mg, 10mg and 20mg of Desloratadine in patients with acquired cold urticaria (ACU)
    Medical condition: Chronic urticaria is characterized by the spontaneous development of wheal and flare type skin reactions.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009869 Cold urticaria LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-005797-31 Sponsor Protocol Number: 701004.01.007 Start Date*: 2008-08-14
    Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG
    Full Title: Efficacy and tolerability of EPs® 7630 film-coated tablets in patients (>=18 years old) with Acute Rhinopharyngitis (ARP)
    Medical condition: Adult patients suffering from Acute Rhinopharyngitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000938 Acute nasopharyngitis (common cold) LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-000057-31 Sponsor Protocol Number: ESTUAR001 Start Date*: 2012-03-19
    Sponsor Name:THERANOR sprl
    Full Title: Multicentre, randomised, double-blind, parallel, placebo-controlled study evaluating the efficacy and safety of Early Self-Treatment of viral Upper respiratory tract infections with homeopathic ora...
    Medical condition: Viral upper respiratory tract infections
    Disease: Version SOC Term Classification Code Term Level
    14.1 10018065 - General disorders and administration site conditions 10022004 Influenza like illness PT
    14.1 10021881 - Infections and infestations 10010106 Common cold LLT
    14.1 10021881 - Infections and infestations 10000938 Acute nasopharyngitis (common cold) LLT
    14.1 10021881 - Infections and infestations 10046300 Upper respiratory infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue Nov 04 08:14:19 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA